Literature DB >> 21944666

Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients.

Céline Maréchal1, Emmanuel Coche, Eric Goffin, Anca Dragean, Georg Schlieper, Pauline Nguyen, Jürgen Floege, Nada Kanaan, Olivier Devuyst, Michel Jadoul.   

Abstract

BACKGROUND: Vascular calcification independently predicts cardiovascular disease, the major cause of death in kidney transplant recipients (KTRs). Longitudinal studies of vascular calcification in KTRs are few and small and have short follow-up. We assessed the evolution of coronary artery (CAC) and thoracic aorta calcification and their determinants in a cohort of prevalent KTRs. STUDY
DESIGN: Longitudinal. SETTING & PARTICIPANTS: The Agatston score of coronary arteries and thoracic aorta was measured by 16-slice spiral computed tomography in 281 KTRs. PREDICTORS: Demographic, clinical, and biochemical parameters were recorded simultaneously. OUTCOMES & MEASUREMENTS: The Agatston score was measured again 3.5 or more years later.
RESULTS: Repeated analyzable computed tomographic scans were available for 197 (70%) KTRs after 4.40 ± 0.28 years; they were not available for the rest of patients because of death (n = 40), atrial fibrillation (n = 1), other arrhythmias (n = 4), refusal (n = 35), or technical problems precluding confident calcium scoring (n = 4). CAC and aorta calcification scores increased significantly (by a median of 11% and 4% per year, respectively) during follow-up. By multivariable linear regression, higher baseline CAC score, history of cardiovascular event, use of a statin, and lower 25-hydroxyvitamin D(3) level were independent determinants of CAC progression. Independent determinants of aorta calcification progression were higher baseline aorta calcification score, higher pulse pressure, use of a statin, older age, higher serum phosphate level, use of aspirin, and male sex. Significant regression of CAC or aorta calcification was not observed in this cohort. LIMITATIONS: Cohort of prevalent KTRs with potential survival bias; few patients with diabetes and nonwhites, limiting the generalizability of results.
CONCLUSION: In contrast to previous small short-term studies, we show that vascular calcification progression is substantial within 4 years in prevalent KTRs and is associated with several traditional and nontraditional cardiovascular risk factors, some of which are modifiable.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21944666     DOI: 10.1053/j.ajkd.2011.07.019

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  35 in total

Review 1.  Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities.

Authors:  Takashi Hirukawa; Takatoshi Kakuta; Michio Nakamura; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2015-05-02       Impact factor: 2.801

2.  Calcification Propensity and Survival among Renal Transplant Recipients.

Authors:  Charlotte A Keyzer; Martin H de Borst; Else van den Berg; Willi Jahnen-Dechent; Spyridon Arampatzis; Stefan Farese; Ivo P Bergmann; Jürgen Floege; Gerjan Navis; Stephan J L Bakker; Harry van Goor; Ute Eisenberger; Andreas Pasch
Journal:  J Am Soc Nephrol       Date:  2015-04-29       Impact factor: 10.121

Review 3.  Vascular calcification, bone and mineral metabolism after kidney transplantation.

Authors:  Luis D'Marco; Antonio Bellasi; Sandro Mazzaferro; Paolo Raggi
Journal:  World J Transplant       Date:  2015-12-24

Review 4.  Mineral and bone disorder after kidney transplantation.

Authors:  Pahnwat T Taweesedt; Sinee Disthabanchong
Journal:  World J Transplant       Date:  2015-12-24

Review 5.  Vascular calcification: When should we interfere in chronic kidney disease patients and how?

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-09-06

6.  Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study.

Authors:  Joseph A Delaney; Nils Lehmann; Karl-Heinz Jöckel; Sammy Elmariah; Bruce M Psaty; Amir A Mahabadi; Matt Budoff; Richard A Kronmal; Khurram Nasir; Kevin D O'Brien; Stefan Möhlenkamp; Susanne Moebus; Nico Dragano; Almut G Winterstein; Raimund Erbel; Hagen Kälsch
Journal:  Atherosclerosis       Date:  2013-05-14       Impact factor: 5.162

7.  Klotho upregulation by rapamycin protects against vascular disease in CKD.

Authors:  Takayuki Hamano
Journal:  Kidney Int       Date:  2015-10       Impact factor: 10.612

8.  Lowering vascular calcification burden in chronic kidney disease: Is it possible?

Authors:  Sinee Disthabanchong
Journal:  World J Nephrol       Date:  2013-08-06

Review 9.  Coronary artery calcium scoring, what is answered and what questions remain.

Authors:  George Youssef; Matthew J Budoff
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

10.  Renal allograft implantation on prosthetic vascular grafts: short- and long-term results.

Authors:  Damiano Patrono; Robert Verhelst; Antoine Buemi; Pierre Goffette; Luc De Pauw; Nada Kanaan; Eric Goffin; Martine De Meyer; Michel Mourad
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.